Delivery Order 75N92019D00016-75N92024F00001
Award Date 12/19/23
Potential Completion Date 6/30/24
Potential Value $213K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract, valued at $1,677,614.67, is for the Gene Therapy Resource Program (GTRP), which supports translational gene therapy research by providing resources and services from three core laboratories: the Pharmacology and Toxicology Core Laboratory, the...
- This is a delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania (Penn) to support the Gene Therapy Resource Program (GTRP). The $1,671,379.55 cost-no-fee contract is for Penn's Preclinical Vector Core Laboratory to provide scientific activities related to gene therapy. The award has a completion date of July 5, 2024 and does not have a set-aside designation. Penn is a leading private research university...
- The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, has been awarded a delivery order against the Gene Therapy Resource Program (GTRP) by the National Heart, Lung and Blood Institute of the National Institutes of Health. Valued at $1,454,186.49, this cost-no-fee contract calls for the prime contractor to perform preclinical vector core laboratory scientific activities under Task Area B of the GTRP. Place of performance will be...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Delivery Order to The Trustees of the University of Pennsylvania (Penn) on August 23, 2019 with a potential value of $1,408,152.00 for "TASK AREA B: PRE-CLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES" under the Gene Therapy Resource Program (GTRP). This is a Cost No Fee contract with a completion date of September 22, 2021. Penn is a private university...
- This $14,424.00 firm fixed-price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The award, which does not have a set-aside designation, is described as QTE#27207 and has an ultimate completion date of August 11, 2023. The University of Pennsylvania is a renowned private...
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,371.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is for the NHLBI's DIR Graft Lungevity Study, which requires obtaining samples and data. The contract has an ultimate completion date of August 31, 2025 and was awarded on September...
- This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian federal agency, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $12,427,447.18 contract is for a randomized clinical trial of genotype-guided dosing of warfarin therapy. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a large research...
- This is a $150,000.00 grant award to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for a research program to execute a balanced science program based on guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and direction from Congress. The award is from a civilian federal agency, the Shared Services Center, and does not have a set-aside designation. The University of...
- The U.S. National Heart Lung and Blood Institute (NHLBI) awarded a $598,672.91 cost-plus-fixed-fee task order contract to The Children's Hospital of Philadelphia (CHOP) for the Gene Therapy Resource Program (GTRP) AAV Vector Production Core Lab. This task order, which is part of a larger GTRP program, has a period of performance through May 31, 2017 and a current funding level of $325,007. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health to the Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, to conduct biomedical research, data analysis, and other scientific activities supporting public health objectives. The $885,000.00 contract is a definitive contract with a time and materials pricing type, with a completion date of March 15, 2005. The contract does not have a set-aside...